 management fails. Cilostazol
is an antiplatelet that has been shown to have beneficial effects for patients wtih intermittent claudication, however, it is not a first-line medication. Lastly, while follow-up is
important in the management of PAD, conservative management should be initiated as
soon as the diagnosis of PAD is made.

93

Introduction
ÄŽ Tip
The term peripheral arterial disease (PAD) is often used interchangeably with peripheral
vascular disease (P